Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.47 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17746974 | 0.89 | KMT2A (0.43) | NOD1EPHX2KMT2A | |
| SCHEMBL17746976 | 0.89 | KMT2A (0.43) | NOD1EPHX2KMT2A | |
| SCHEMBL1959616 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL32889378 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL29669622 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL15387262 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL17747068 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL1960769 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL1958048 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 | |
| SCHEMBL29669584 | 0.88 | NOD1 (0.56) | NOD1KMT2AFAAHMEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3075247-B1 | CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS | BIOSIGHT LTD (IL) | 2022-10-12 | — | — | EP | disclosed |